Of the few studies that have investigated the effect of Akt2 isoform ablation on tumor initiation and progression [19], [21], [45], only in mouse models of Neu- and PyMT-driven mammary carcinogenesis was Akt2 identified as a putative tumor suppressor [21]. This evidence concerns the gene AKT2 and neoplasm.